BLUE

Bluebird Bio Stock Price

62.49
0.00 (0.0%)
62.49
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Bluebird Bio Inc BLUE NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.00 0.0% 62.49 0.00 0.00 0.00 62.49 04:00:00
Bid Price Ask Price Spread Spread % News
59.75 72.23 12.48 17.28% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 62.49 USD

Bluebird Bio Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.14B 66.22M 45.49M $ 44.67M $ - -14.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Bluebird Bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BLUE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week62.9568.3961.904663.72756,125-0.46-0.73%
1 Month63.5568.3959.47264.26722,817-1.06-1.67%
3 Months59.8773.5057.202764.201,029,4992.624.38%
6 Months90.3392.0038.9559.601,193,037-27.84-30.82%
1 Year120.01124.15538.9572.561,078,293-57.52-47.93%
3 Years95.00236.167138.95117.44846,775-32.51-34.22%
5 Years133.03236.167135.3795.27945,081-70.54-53.03%

Bluebird Bio Description

bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.


Your Recent History
NASDAQ
BLUE
Bluebird B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.